← The SEC Ephemeris: the whole map
AFT Pharmaceuticals Ltd. sirolimus
In the graph: all 4 documents (15 pages).
- Application
- NDA 218528
- Ticker
- AFT Pharmaceuticals Ltd.
- Product
- sirolimus
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- January 25, 2024 · June 30, 2022 · November 6, 2020 · December 22, 2017
From FDA letters and SEC filings. Not investment or medical advice.